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1 Abstract 
Herpes simplex virus type 1 (HSV-1) is a double-stranded DNA virus that infects humans 
and, after a primary lytic infection, establishes lifelong latency in the sensory neurons of the 
trigeminal ganglia (TG). HSV-1 latency is accompanied by a chronic immune cell infiltration 
of the TG, the infiltrate being mainly composed of CD8+ T cells. These T cells are believed to 
control viral latency, but cellular and viral factors like viral microRNAs are also considered to 
play a crucial role in the establishment and maintenance of viral latency.  
In the present work, it was investigated whether the tissue-infiltrating T cells are clonally 
expanded, which would indicate that these T cells are activated by antigen. By applying 
complementarity determining region 3 (CDR3) spectratyping and immunohistochemistry, 
several clonal expansions were identified in the TG-resident T cells. In addition, several 
T cells were present that seemed to be unspecific bystander T cells. Strikingly, some 
expanded T-cell clones were present in the right and left TG of the same individual. This 
strongly suggests that similar antigens are present in both TG and that the infiltration of 
immune cells to the TG is driven by antigen. 
The morphology of the TG was investigated by immunohistochemistry and in situ hybridiza-
tion. Analysis of the distribution of T cells throughout the TG provided puzzling results: 
unexpectedly, most neurons surrounded by T cells did not harbour the only known prominent 
transcript during latency, the latency associated transcript (LAT). Whether these neurons do 
actually harbour latent virus was addressed by a combination of LAT in situ hybridisation, 
T-cell immunohistochemistry, and single cell analysis of laser microdissected sensory 
neurons by PCR. This analysis revealed that only LAT+ neurons were harbouring HSV-1 
DNA and viral microRNAs. Also, mRNA for a viral gene product was only detected in LAT+ 
neurons. All analysed LAT– neurons were devoid of viral microRNAs and DNA of HSV-1. 
DNA of HSV-2 or varicella-zoster virus (VZV) was not detected in any of the excised 
neurons. Altogether this indicates that in the vast majority of infected human neurons, HSV-1 
latency is not directly controlled by T cells, but rather by cellular or viral factors like the 
miRNAs. Our data suggest that CD8+ T cells only come into action if these mechanisms are 
overrun. 
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2 Introduction 
 
2.1 Immune system 
The body has to constantly protect itself from a variety of pathogens like viruses, bacteria, 
fungi or parasites, as well as from mutated autologous cells. It is the role of the immune 
system to protect the organism against such threats. Two systems have evolved to accomplish 
this. The first line of defence is the innate immune response. Immediately after crossing the 
surface barriers of skin or mucosa, pathogens are identified as non-self by invariant receptors 
recognising common features of pathogens. This then triggers an inflammatory process. The 
innate immune system consists of white blood cells like macrophages, dendritic cells, granu-
locytes, mast cells, and natural killer cells, as well as the soluble factors of the complement 
system. If pathogens overcome these first control mechanisms, the innate immune system 
paves the way for the adaptive immune response and prevents accelerated pathogen repro-
duction whilst the adaptive response is generated. In contrast to the innate immune system, 
the effectors of the adaptive immune response recognise specific antigens and are able to 
memorise them. These effectors of the adaptive immune response are the lymphocytes, 
divided into T cells and B cells. T cells play the central role in cell-mediated immunity 
whereas B cells, by generating specific antibodies, represent the humoral branch of the adap-
tive immune response. The downside of such a highly specific immune response is the rejec-
tion of transplants or autoimmune disorders of the immune system. 
 
2.1.1 T cells 
T cells originate from lymphoid progenitor cells in the bone marrow but their maturation 
mostly takes place in the thymus (Chaplin, 2010). The rearrangement of the T-cell receptor 
(TCR), as well as selection of T cells with a functional, non-autoreactive TCR, takes place 
there. After maturation, T cells are released from the thymus and migrate between the blood-
stream and lymphatic organs as mature naïve T cells, until they encounter their respective 
antigen. Activation of T cells depends on presentation of antigens by antigen-presenting cells 
(APC) on major histocompatibility complex (MHC), and a further co-stimulatory signal. 
Upon antigen recognition T cells proliferate, giving rise to a clonal expansion, and finally 
differentiate into effector T cells. Most effector T cells die eventually, but some persist after 
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antigen clearance and differentiate into memory cells, which can be reactivated quickly upon 
a second encounter with the respective antigen. 
There are two main subsets of T cells (Chaplin, 2010), each carrying one of two different 
surface receptors, CD4 or CD8. CD4+ T cells recognise antigens presented on MHC class II, 
which is present on immune cells only. The main function of CD4+ T cells is to modulate the 
actions of other immune cells by the secretion of cytokines or direct interaction. There are a 
variety of regulatory T cells of both subsets, for example the most commonly known CD4+ 
FoxP3+ regulatory T cells (Sakaguchi et al., 2009). Regulatory T cells are able to suppress 
other immune cells and play a crucial role in the induction of immune tolerance. CD8+ T cells 
are stimulated by antigen presented on MHC class I, which is present on most cells of the 
body. The major task of CD8+ T cells is to detect and destroy cells that are infected by intra-
cellular pathogens or altered by mutagenesis. As this work focuses on herpesvirus infection, 
both CD8+ T cells, key players in anti-viral immunity, as well as MHC class I molecules, are 
explained in detail in the following sections. 
 
2.1.1.1 CD8+ T cells 
CD8+ T cells, also called cytotoxic T cells, are capable of inducing death in somatic cells 
infected by a virus or other intracellular pathogens, as well as in tumour cells (Russell and 
Ley, 2002). The characteristic feature of these T cells is the surface molecule CD8, which 
binds to MHC class I molecules and stabilises the interaction of the TCR with the MHC 
molecule. Upon recognition of a specific peptide:MHC class I complex by the TCR, and a co-
stimulatory signal provided by the APC, naïve CD8+ T cells differentiate into cytotoxic 
T cells. Without the co-stimulatory signal, anergy or apoptosis is induced in T cells reactive to 
peptide:MHC complexes, preventing immune responses to self antigens. If a fully differenti-
ated CD8+ T cell encounters its respective antigen, the TCRs and the associated co-receptors 
cluster at the site of cell-cell contact, forming an immunological synapse. This also leads to a 
reorientation of the cytoskeleton, in order to focus the release of effector molecules. There are 
two classes of effector molecules produced by effector CD8+ T cells: cytokines and cytot-
oxins. Cytokines are small soluble proteins that can modulate the actions of cells. The major 
cytokine released by CD8+ T cells is interferon-γ (IFN-γ), which induces a non-cytotoxic 
antiviral response, but cytokines of the tumour necrosis factor (TNF) family are also secreted 
by CD8+ T cells. The second set of effector molecules are the cytotoxins, which are synthe-
sised and stored in specialised cytotoxic granules during the activation of a naïve CD8+ T cell 
(Russell and Ley, 2002). Perforin, one of the cytotoxic proteins, delivers the other contents of 
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the cytotoxic granules to the membrane of the target cell. Another component of the granules 
is a family of serine proteases, the granzymes, which trigger apoptosis in the target cell. Gran-
zyme B cleaves and activates caspase-3, which in turn triggers the caspase cascade, leading to 
the degradation of DNA and apoptosis. The last component of the cytotoxic granules in 
humans, granulysin, has antimicrobial properties. CD8+ T cells can also induce apoptosis in 
other cells by the interaction of Fas with Fas ligand. As both transmembrane proteins are 
expressed on activated lymphocytes, this mechanism is primarily employed to control 
lymphocyte numbers. The mechanism by which CD8+ T cells induce apoptosis in target cells 
is highly precise, as only infected target cells are killed while neighbouring healthy cells are 
spared. 
 
2.1.1.2 T-cell receptor 
T cells recognise their respective antigen, presented on MHC, via the TCR expressed on the 
surface of all T cells. The TCR is a heterodimer, which in the majority of T cells is composed 
of one α- and one β-chain (Rudolph et al., 2006). Each of the two TCR chains has a C-termi-
nal transmembrane region with a short cytoplasmic tail. The extracellular N-terminal portion 
consists of a constant (C) and a variable (V) region. Peptide:MHC complexes are recognised 
via the V region. The whole TCR complex consists of one α and β TCR chain together with 
the CD3 complex (Clevers et al., 1988). The CD3 complex, which is composed of one γ- and 
one δ-chain, as well as two ε- and ζ-chains, all with long cytoplasmic tails, is involved in 
signal transduction. The structure of the TCR is depicted in Fig. 1. Each TCR complex is 
associated with the co-receptor CD4 or CD8 which binds to MHC class I or II, respectively. 
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Fig. 1: Schematic model of the T-cell receptor complex. 
Depicted is an α:β TCR in blue, which recognises the peptide:MHC class I complex on somatic cells. 
Signalling occurs via the CD3 complex (in orange), consisting of CD3ε:CD3δ and CD3ε:CD3γ 
heterodimers and one ζ:ζ homodimer. Further, the α:β heterodimeric CD8 co-receptor is depicted here 
in purple. The CD8 molecule binds to MHC class I present on most somatic cells. (Scheme according 
to (Murphy et al., 2008)) 
 
The variability of the TCR, and therefore the ability to recognise a broad spectrum of anti-
gens, is generated by somatic recombination – a more or less random joining of gene 
segments – which takes place during T-cell development in the thymus. The β-chain of the 
TCR is composed of a variable (V), a diversity (D), a joining (J), and a constant (C) gene 
segment, whereas the α-chain lacks the D segment (Fig. 2). The α-chain locus on chromo-
some 14 consists of 70-80 Vα, 61 Jα, and 1 Cα gene segments. The β-chain locus, on the 
other hand, is located on chromosome 7 and encodes for 52 Vβ, 2 Dβ, 13 Jβ, and 2 Cβ gene 
segments (Arden et al., 1995) (Lefranc and Lafranc, 2001). The rearrangement of the different 
loci is mediated by two enzymes, the recombination activation genes (RAG) 1 and 2. The 
sequence of gene rearrangement in α:β T cells starts with the rearrangement of the β-chain 
locus in CD4 and CD8 double-negative thymocytes. First, Dβ segments rearrange to Jβ 
segments and subsequently the Vβ segment rearranges to DJβ segments (Krangel, 2009). The 
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successful rearrangement of one β-chain leads to the expression of this β-chain, together with 
a surrogate α-chain on the surface of the thymocyte, and gene rearrangement is halted. This 
ensures the allelic exclusion of the β-chain, followed by a rapid cell proliferation and expres-
sion of both TCR co-receptors CD4 and CD8. When the proliferation phase ends, rearrange-
ment of Vα with Jα is induced.  
During TCR rearrangement, random nucleotides are added or deleted at the Vβ-Dβ and Dβ-Jβ 
junctions, as well as at the Vα-Jα junctions, thus generating an extremely variable region, the 
complementarity determining region 3 (CDR3). This hypervariable region forms the antigen-
binding site of the TCR (Rudolph et al., 2006). The deletion or insertion of nucleotides leads 
to variation in length of approximately 6 to 8 amino acids between different T-cell clones. 
The CDR1 and 2, which mainly mediate contact to the MHC, are germline encoded within the 
V gene segments. The combination of different gene segments, the pairing of two TCR chains 
and the insertion or deletion of random nucleotides leads to a possible total diversity ranging 
from 1015 to 1020 TCR molecules (Miles et al., 2011). 
 
 
Fig. 2: Somatic recombination of β-chain and α-chain V(D)J segments. 
TCR α and β genes are rearranged during T-cell development in the thymus. One of each of the V(D)J 
gene segments is chosen randomly, and gene segments are subsequently linked by somatic recombi-
nation. In the final TCR-molecule, the CDR3 region, composed of the Vβ-Dβ-Jβ and Vα-Jα junctions, 
forms the antigen-binding cleft. (Scheme according to (Murphy et al., 2008))  
 
Once a functional α:β TCR can be expressed on the cell surface, double-positive thymocytes 
are selected by their recognition of MHC loaded with self-antigen. Thymocytes reacting too 
strongly or not at all to self-peptide:MHC complexes are deleted in the thymus. CD8 and CD4 
double-positive thymocytes that react with low affinity to MHC class I or MHC class II 
become CD4+ or CD8+ T cells, respectively, and are released into the bloodstream (Chaplin, 
2010).  
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Recognition of a specific peptide:MHC class I complex by the TCR of a T cell leads to clus-
tering of TCR components, with subsequent phosphorylation by the TCR-associated tyrosine 
kinases Lck and Fyn. This leads to recruitment of ZAP-70, which in turn induces a signal 
transduction cascade leading to an increase of the intracellular calcium concentration and 
finally to the activation of several transcription factors (Lin and Weiss, 2001).  
As many viruses have evolved strategies to downregulate MHC class I expression, CD8+ 
T cells need to be able to react to very low levels of antigens to evoke an effective immune 
response. As a matter of fact, it was shown that some CD8+ T cells may even become acti-
vated by such low numbers as one to three peptide:MHC class I complexes (Sykulev et al., 
1996) (Purbhoo et al., 2004).  
 
2.1.2 Major Histocompatibility Complex 
The major histocompatibility complex (MHC) is a large cluster of genes, encoding membrane 
glycoproteins that bind pathogen-derived peptides and display them on the cell surface to 
T cells. In humans, these genes are encoded on chromosome 6 and are called human leuko-
cyte antigen (HLA). To defend the organism against a vast variety of pathogens, the MHC has 
to be able to bind a wide range of pathogen-derived peptides. Therefore, the MHC locus is 
polygenic and both MHC alleles are expressed co-dominantly. Further, the MHC genes are 
highly polymorphic, meaning there are various different alleles present in the population. 
There are two main classes of MHC molecules. MHC class I, which is expressed on almost all 
somatic cells except the erythrocytes, presents peptides derived from the cytosol to CD8+ 
T cells. On some somatic cells such as neurons, expression of MHC class I molecules occurs 
only after induction by an inflammatory milieu (Neumann et al., 1995). CD4+ T cells on the 
other hand, recognise antigen only in the context of MHC class II, which is expressed solely 
on immune cells like macrophages, dendritic cells or B cells. Peptides derived from proteins 
in intracellular vesicles, taken up by endocytosis, are presented on MHC class II. 
The MHC further encodes many other proteins involved in antigen processing and the 
production of peptide:MHC complexes. 
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2.1.2.1 MHC class I 
The MHC class I molecule is a heterodimer consisting of a membrane anchored α-chain and a 
non-covalently associated β2-microglobulin (Germain, 1994). The α-chain, encoded on chro-
mosome 6 within the MHC locus, forms three domains, the α1, α2, and α3 domains (Fig. 3). 
In humans, genes encoding for the MHC class I α-chain are called HLA-A, -B, and-C. The 
highest allelic variation occurs within the α-1 and α-2 domains, which form the peptide-bind-
ing cleft. The β2-microglobulin, in contrast, is not polymorphic and not encoded within the 
MHC locus, but on chromosome 15. Binding of the TCR co-receptor CD8 is mediated by the 
α3 domain, which also binds the β2-microglobulin. The peptide-binding cleft of MHC class I 
molecules binds peptides typically 8 to 10 amino acids in length via hydrogen bonds and ionic 
interactions (Rudolph et al., 2006).  
 
 
Fig. 3: Structure of the MHC class I molecule and binding of the TCR. 
A: The MHC class I heterodimer composed of one α-chain, which folds into three domains 
(α1, α2, and α3) and the β2-microglobulin. (Scheme according to (Murphy et al., 2008)) B and C: 
Recognition of the peptide:MHC complex by the TCR. The CDRs of the TCR are binding the 
MHC molecule as well as the peptide (Rudolph et al., 2006). 
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Viruses and some other pathogens replicate inside their host cells. Some pathogen-derived 
proteins are degraded by the proteasome complex and subsequently transported into the 
lumen of the endoplasmic reticulum (ER) where the MHC class I molecules are synthesised. 
Transport of cytosolic peptides into the ER lumen is mediated by two heterodimer-forming 
proteins in the ER membrane, the transporters associated with antigen processing-1 and -2 
(TAP1 and TAP2). In the ER lumen, the MHC class I α-chain is associated with chaperones 
until it finally binds β2-microglobulin and an adequate peptide. The final peptide:MHC class I 
complex is transported to the cell membrane via the Golgi apparatus (Germain, 1994). Many 
components of the antigen-presenting pathway are upregulated by IFN-γ, a cytokine produced 
upon viral infection. 
MHC class I molecules can also present exogenous peptides by a mechanism called cross-
presentation. This mechanism ensures that CD8+ T cells can respond to pathogens that do not 
infect APCs. The main types of APCs able to present extracellular proteins on MHC class I 
are dendritic cells, which are then able to activate naïve CD8+ T cells (Heath and Carbone, 
2001). 
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2.2 Herpes simplex virus type 1 
 
Herpes simplex virus type 1 (HSV-1) is a herpesvirus which frequently infects humans, 
causing a variety of diseases ranging from relatively harmless cold sores to ocular herpes, the 
leading cause of blindness caused by infection in industrialised countries. After primary 
infection, usually occurring via the mucosa of the mouth, HSV-1 establishes latency in 
sensory neurons, a state that lasts for the life of the host. Viral latency is characterised by 
retention of a functional viral genome and very limited gene expression without production of 
infectious virus particles. Due to certain triggers, such as stress, UV light, or immune suppres-
sion, the virus can reactivate from the latent state and cause recurrent infections at the original 
site of infection. As well as cell culture systems, several animal models of infection, including 
mice and rabbits, are used to study the life cycle of HSV-1. 
 
2.2.1 Taxonomy and Structure 
HSV-1 belongs to the family Herpesviridae, a group of large double-stranded (ds) DNA 
viruses infecting a broad range of animals from molluscs to higher vertebrates (Modrow et al., 
2010). Even though infections by different herpesviruses lead to different symptoms, particle 
morphology and molecular properties are very similar within this virus family. The name 
herpes is derived from the Greek word “herpein” meaning “to creep” which refers to the 
creeping spread of HSV-1 skin lesions (Whitley and Roizman, 2001). The characteristic 
feature of all herpesviruses is the ability to switch between lytic infection and latency. 
HSV-1 virions consist of an icosahedral nucleocapsid composed of 162 capsomers that 
contains the dsDNA genome, a lipid envelope with up to 12 embedded glycoproteins, and the 
protein-filled tegument in between (Fig. 4). The viral glycoproteins (gB, gC, gD, gE, gG, gH, 
gI, gJ, gK, gL, gM, gN) play a role in adsorption to and penetration of the cell, as well as in 
eliciting protective antibodies. Some of the tegument proteins, which enter the host cell along 
with the virus, play important regulatory functions in inducing viral replication, such as VP16 
and vhs (virus host shutoff) (Modrow et al., 2010).  
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Fig. 4: Structure of the HSV-1 virion. 
A: Electron microscopy micrograph of a HSV-1 virion (courtesy of Jay Brown, University of 
Virginia). B: Schematic structure of the HSV-1 virion, showing the lipid envelope containing glyco-
proteins, the nucleocapsid and the tegument.  
 
The dsDNA genome of HSV-1 – about 152,000 base pairs in length – is divided into a long 
and a short segment. The virus genome encodes for about 84 proteins with multiple functions 
(Whitley and Roizman, 2001), and in total has approximately 89 open reading frames (ORF), 
some of them partially overlapping (Rajcani et al., 2004). Six distinct regions can be found on 
the HSV-1 genome (Fig. 5). The unique long (UL) and short (US) regions are flanked by two 
pairs of inverted repeats, the long repeats (RL / b) and the short repeats (RS / c). Additionally, 
at both ends of the linear molecule, there are the relatively short a sequences. They function in 
circularisation of the DNA upon infection. There are three origins of replication (ori), where 
the replication of the genome starts. One resides in the middle of the UL region (oriL) and the 
other two are in the RS (oriS) (Modrow et al., 2010). Apart from a few exceptions, most 
HSV-1 transcripts are not spliced (Rajcani et al., 2004). Upon infection the genome circu-
larises and exists as an episome in the nucleus of the host cell. 
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Fig. 5: Scheme of the HSV-1 genome.  
The HSV-1 genome consists of one unique long (UL) and one unique short (US) sequence being sepa-
rated by inverted repeats at the termini (TRL and TRS) as well as in the middle (IRL and IRS). 
 
Members of the Herpesviridae family can be grouped by their host cell range and their repli-
cative properties (Wagner and Bloom, 1997). Alphaherpesviruses can infect a relatively broad 
spectrum of host cells, have a short replication cycle, and establish lifelong latency in 
neurons. Betaherpesviruses, on the other hand, have a narrow host cell range, a slow replica-
tion cycle, and establish latency in leukocytes. The third group of herpesviruses, the 
Gammaherpesviruses, have a narrow host cell range, establish latency in B lymphocytes, and 
vary in length of the replication cycle. The Gammaherpesviruses can cause cancer by induc-
ing proliferation in the infected cells. Table 1 lists the eight herpesviruses infecting humans, 
grouped by subfamily. 
 
Table 1: Human herpesvirus classification of the Herpesviridae Family 
(According to the International Committee on Taxonomy of Viruses) 
Subfamily Genus Species 
Alphaherpesvirinae Simplexvirus 
 
Varicellovirus 
Herpes simplex virus type 1 
Herpes simplex virus type 2 
Varicella-zoster virus 
Betaherpesvirinae Cytomegalovirus 
Roseolovirus 
Human cytomegalovirus 
Human herpesvirus 6 
Human herpesvirus 7 
Gammaherpesvirinae Lymphocryptovirus 
Rhadinovirus 
Epstein-Barr virus 
Kaposi’s-sarcoma-associated herpesvirus 
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2.2.2 Lytic Infection 
HSV-1 infection of epithelial or mucosal cells results in lytic infection of the host cell 
followed by production of infectious virus. During HSV-1 lytic infection, viral genes are 
expressed in a highly regulated cascade. Lytic infection usually results in the release of infec-
tious virus particles and death of the host cell. 
 
2.2.2.1 Entry into the host cell 
Infection of a host cell begins with the attachment of HSV-1 to host cell receptors via glyco-
proteins in its lipid envelope (Whitley and Roizman, 2001). Attachment is mediated by bind-
ing of gC to heparan sulphate proteoglycan on the host cell, followed by binding of gD to a 
modified heparan sulphate or HVEM (herpesvirus entry mediator). Fusion of the host cell 
membrane with the virus membrane requires formation of a complex of gB with gH/gL 
(Eisenberg et al., 2011), after which the capsid, along with tegument proteins, gets released 
into the host cytoplasm. HSV-1 can also enter host cells via receptor-mediated endocytosis or 
cell to cell transmission (Modrow et al., 2010). The capsid and some tegument proteins are 
then transported via microtubules to nuclear pores, where viral DNA is released into the 
nucleus. Other tegument proteins, such as vhs, appear to remain in the cytoplasm. Vhs causes 
disaggregation of polyribosomes and degradation of cellular RNA thereby priming the cell to 
virus production (Wagner and Bloom, 1997). Upon entry into the nucleus, viral DNA is asso-
ciated with histones and therefore silenced (Roizman, 2011).  
 
2.2.2.2 Viral Replication 
Viral genes are transcribed in a sequential manner. First the immediate early or α-genes are 
transcribed, which in turn activates transcription of early or β-genes. Finally, after viral DNA 
synthesis, the late or γ-genes are transcribed. The replication cycle of HSV-1 is very short, as 
mature virions are formed within 8 hours after infection in some cell culture systems (Wagner 
and Bloom, 1997). A scheme of the lytic cycle of HSV-1 infection is depicted in Fig. 6. 
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Fig. 6: Lytic life cycle of HSV-1. 
Primary lytic infection of epithelial or mucosal cells starts with attachment and penetration of HSV-1. 
The capsid is then transported to the nuclear membrane and the linear dsDNA is injected into the 
nucleus. Subsequently, the genome circularises and the cascade of viral gene expression is induced by 
the binding of VP16 together with HCF1 to α-gene promoters. Assembled virions bud through the 
nuclear membranes, are enveloped at the trans-Golgi network and released from the infected cell. 
 
Transcription of α-genes 
Binding of the α-gene promoter by the tegument protein VP16, together with two cellular 
factors Oct1 (octamer binding protein 1) and HCF1 (host cell factor 1), leads to recruitment of 
a histone demethylase, which demethylates histones present on viral DNA and thereby initi-
ates transcription of α-genes (Roizman, 2011). The five α-genes named infected cell protein 
(ICP) ICP0, ICP4, ICP22, ICP27, and ICP 47 are transcribed first (Wagner and Bloom, 1997). 
The capped and polyadenylated α-mRNAs are transported into the cytoplasm, where they are 
translated into proteins that are in turn re-imported into the nucleus, where they promote tran-
scription of early genes. ICP0, ICP4, and ICP27 are potent transactivators of viral early and 
late gene transcription, whereas ICP22 promotes transcription of viral late genes (Wagner and 
Bloom, 1997). ICP47 functions in export of viral mRNA from the nucleus (Modrow et al., 
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2010). Apart from activating RNA polymerase II, ICP4 can also downregulate expression of 
the latency-associated transcript (LAT) and all α-genes, including itself (Deluca, 2011). ICP0 
promotes viral early transcription by binding to a repressor complex 
(HDAC/CoREST/LSD1/REST) which then gets detached from the viral genome (Roizman, 
2011). Another function of ICP0 is mediated by its E3 ubiquitin ligase activity which marks 
proteins for proteasomal degradation. ICP0 was found to induce degradation of ND10 nuclear 
bodies, which are dynamic structures in the nucleus consisting of a large number of proteins 
with functions in stress response, transcriptional control and innate immune response (Everett, 
2011). 
 
Transcription of β-genes 
Presence of viral α-proteins in the nucleus leads to expression of β-genes, which all encode 
for non-structural proteins involved in the replication of viral DNA. Seven β-proteins need to 
be present in the nucleus to ensure viral DNA replication: the viral DNA polymerase (UL30), 
the helicase/primase complex (UL5, UL52, UL8), an ori binding protein (UL9) and two DNA 
binding proteins (UL42 and UL29) (Ward and Weller, 2011). Another important β-protein is 
the viral thymidine kinase, which catalyses the phosphorylation of thymidine. After accumu-
lation of sufficient levels of β-proteins in the nucleus, synthesis of multiple copies of viral 
DNA by the viral DNA polymerase is initiated. This also leads to a shutdown of IE and E 
gene expression (Wagner and Bloom, 1997). DNA replication takes place in replication 
compartments in the nucleus, forming at previous ND10 sites which were dissociated by the 
E3 ligase activity of ICP0 (Ward and Weller, 2011). Replication of viral DNA starts at the 
oris and occurs by the rolling circle principle, leading to viral DNA containing multiple units 
of the viral genome in concatemers.  
 
Transcription of γ-genes 
The HSV-1 γ-genes, which are mainly transcribed after DNA replication, encode for 30 
structural or core proteins. These genes are subdivided into γ1-genes, expressed in small 
amounts before viral DNA replication, and γ2-genes that are absolutely dependent on DNA 
replication for expression (Wagner and Bloom, 1997). After transcription, the mRNAs are 
exported form the nucleus to the cytoplasm where they are translated into protein. These 
proteins are then transported back into the nucleus, where assembly of the virus capsid and 
subsequent packaging of viral DNA takes place. 
 
Introduction 
16 
2.2.2.3 Nuclear egress and envelopment 
During lytic infection, the nuclear membrane is modified by the insertion of herpes glyco-
proteins. HSV-1 capsids, enclosing the viral DNA, bud through the inner lamella of the 
nuclear membrane, thus acquiring the initial envelope. This envelope then fuses with the outer 
nuclear membrane, and the bare capsids produced are then released into the cytoplasm 
(Baines and Roberts, 2011). At the trans-Golgi network, viral capsids associate with tegument 
proteins including VP16 and vhs, and are finally released at the plasma membrane, with an 
envelope formed by trans-Golgi vesicles. Nucleocapsids associated with tegument can also 
spread to other cells by syncytium formation (Modrow et al., 2010). 
 
2.2.2.4 Lytic cycle proteins and inhibition of host-defence 
Several viral proteins expressed during lytic infection have functions in inhibiting host-
defence. Of the HSV-1 mechanisms known to inhibit anti-viral response, the functions of 
ICP47 are best known. This protein has been demonstrated to bind to the cytoplasmic domain 
of TAP (Hill et al., 1995), which is positioned within the ER membrane. Binding of ICP47 
stops TAP from transporting peptides to the endoplasmic reticulum, where they would be 
associated with MHC class I and presented to CD8+ T cells on the cell surface.  
ICP0 has also been shown to have an effect on host-defence, via its degradation of ND10 
nuclear bodies. These distinct nuclear structures are built up of several proteins, with func-
tions in chromatin modification, DNA damage responses, stress responses, regulation of gene 
expression, and innate immune responses that are upregulated by IFN-γ (Everett, 2011). 
Therefore, HSV-1 ICP0 renders the cell unsusceptible to IFN-γ. The role of ICP0 as an IFN-γ 
antagonist is further emphasised by its ability to work against STAT (Signal Transducer and 
Activator of Transcription) or IFN-γ receptor-dependent repression of the virus (Halford et 
al., 2006). 
An intrinsic mechanism to protect cells against viral infection is the detection of dsRNA by 
host protein kinase R (PKR). Activated PKR can in turn induce the IFN-dependent immune 
response, apoptosis, and activation of the central translation initiation factor eIF-2α, which 
subsequently blocks all protein synthesis. Viral ICP34.5 can prevent this translational block 
(Whitley and Roizman, 2001). Another HSV-1 protein counteracting PKR is Us11. It binds to 
dsRNA, which therefore cannot be recognised by PKR (Modrow et al., 2010). The cellular 
intrinsic defence mechanisms are further impaired by the HSV-1 vhs-induced destruction of 
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cellular mRNA, inhibition of DNA transcription, and blocking of mRNA splicing (Whitley 
and Roizman, 2001). 
Immune evasion mechanisms are also mediated by some of the viral glycoproteins (Modrow 
et al., 2010). For example, gC can bind to the complement component C3b. Furthermore, gE 
and gI bind to the Fc region of antibodies, thereby preventing the binding of the Fc-domain of 
antibodies by immune effector cells. These two glycoproteins also mediate cell-to-cell spread 
of HSV-1 without release of infectious virus, whereby the virus can avoid encounters with 
neutralising antibodies. 
Eliminating infected cells by apoptosis is a crucial mechanism in limiting viral spread. HSV-1 
has evolved several mechanisms to block programmed cell death. For instance, the α-genes 
ICP4, ICP22, and ICP27 are anti-apoptotic proteins (Cotter and Blaho, 2011). Furthermore, 
US3, US11, UL14, gJ, and gD are believed to inhibit apoptosis caused by cell injury (Cotter 
and Blaho, 2011). 
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2.2.3 Latency 
A primary infection with HSV-1, which usually occurs at the oral mucosa, results in lytic 
infection with lysis of the epithelial or mucosal cells, and subsequent release of infectious 
virus. Free HSV-1, released from productively infected cells, can then enter sensory nerve 
fibres innervating the site of inoculation. The virus then travels via retrograde transport to the 
cell body of the neurons, which are located in the trigeminal ganglia (TG). There, HSV-1 
establishes lifelong latency (Baringer and Swoveland, 1973), which is characterised by the 
existence of a functional viral genome without the production of infectious virus (Fig. 7). 
During latency only minimal expression of viral genes occurs. The only transcript abundantly 
expressed is the latency-associated transcript (LAT), but recently minimal expression of other 
viral transcripts has also been described in latently infected human (Derfuss et al., 2007) and 
mouse TG (Kramer and Coen, 1995) (Chen et al., 1997) (Feldman et al., 2002) (Chen et al., 
2002a). Latency is divided into three steps. First, during establishment of latency, viral DNA 
circularises upon entry into the nucleus and is silenced by association with histones. Second, 
throughout the maintenance of latency only minimal expression of viral genes occurs. The 
third step is spontaneous reactivation from latency, when new infectious virions are formed 
(Fig. 8).  
 
2.2.3.1 Establishment of latency 
In human HSV-1 infection, events taking place after primary infection cannot be studied. 
However, studies in the mouse model reveal that entry of the virus into the TG is followed by 
a short phase of increasing virus titres, during which infectious virus can be recovered from 
the TG (Liu et al., 1996). It is not yet resolved whether HSV-1 is transferred from neuron to 
neuron, or if multiple neurons are infected at the periphery. As no local sensory loss induced 
by neuronal death can be observed, it could be speculated that neurons either do not die upon 
viral replication or that viral replication does not take place. Despite this, an infiltration of 
immune cells into the primary infected TG occurs. The initial immune infiltration in the TG is 
composed of cells of the innate immune system (Shimeld et al., 1995) (Liu et al., 1996), 
which later changes, from day seven post infection onwards, to mostly CD8+ T cells of the 
adaptive immune response (Liu et al., 1996). The appearance of CD8+ T cells is concurrent 
with elimination of viral replication (Simmons and Tscharke, 1992). Establishment of viral 
latency is not only promoted by the immune system, however, as HSV-1 was found to estab-
lish latency in the TG of mice deficient in an innate and adaptive immune system (Ellison et 
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al., 2000). Upon entering the nucleus of its host cell, viral DNA immediately circularises and 
is associated with histones (Efstathiou et al., 1986) (Deshmane and Fraser, 1989). HCF1, 
which is needed for induction of viral α-gene expression by VP16, is present in the cytoplasm 
of unstressed neurons, unlike in non-neuronal cells where it is located in the nucleus. Without 
the VP16/HCF1/Oct1 complex, the viral genome remains silenced, as associated histones as 
well as the HDAC/CoREST/LSD1/REST repressor complex, are not removed (Roizman, 
2011) (Fig.7). Active regulation by the virus itself does not seem to be a prerequisite for 
establishing latency, as no viral gene product was shown to be absolutely required (Wagner 
and Bloom, 1997). Thus, latent infection seems to be the consequence of a failure to enter the 
lytic cascade.  
 
 
Fig. 7: Establishment of HSV-1 latency. 
HSV-1 enters axonal termini at the site of the primary infection. Viral capsids are transported in a 
retrograde manner to the nerve cell body. Upon injection of viral DNA into the nucleus, the DNA 
circularises, and associates with chromatin. During latency the viral genome persists as an episome. 
As HCF1 is not present in the nucleus of unstressed neurons, the VP16/HCF1 complex cannot initiate 
α-gene expression and thereby viral lytic gene expression is silenced. During latency only LAT is 
expressed. 
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2.2.3.2 Maintenance of latency 
In latently HSV-1-infected sensory neurons, the only abundantly expressed viral gene prod-
ucts are the LATs (Stevens et al., 1987) (Croen et al., 1987). The primary 8.5-kb polyade-
nylated transcript is spliced into a 2-kb LAT stable intron, which accumulates in neuronal 
nuclei (Wagner and Bloom, 1997). It is still a matter of debate whether functional peptides or 
proteins are derived from this transcript (Henderson et al., 2009). As LAT is the only easily 
detectable transcript in latently infected neurons, many functions in establishment and main-
tenance of latency, as well as in reactivation, have been attributed to it. Studies with LAT– 
mutants in animal models of infection suggest a minor role of LAT in latency. It was shown 
that LAT is not essential, because most LAT– mutants do establish latency and can reactivate 
(Perng et al., 1994) (Chen et al., 1997). Furthermore, in mice, not all sensory neurons 
harbouring HSV-1 DNA express LAT to detectable levels (Mehta et al., 1995) (Chen et al., 
2002b). Infection of mice with LAT– mutants did however result in decreased numbers of 
latently infected TG neurons (Thompson and Sawtell, 1997) and a decreased reactivation rate 
in explant cultures of mouse TG (Carr et al., 1998). The importance of LAT in promoting 
spontaneous reactivation seems to vary between species, as the effect of LAT– mutants is 
more prominent in rabbits (Perng et al., 1994) (Hill et al., 1990) than in mice (Margolis et al., 
2007). Spontaneous reactivation of HSV-1 from latency also seems to vary between species 
as it is a much more common event in humans and rabbits than in mice. Therefore, the effect 
of LAT on the latency-reactivation cycle might be underestimated in small animal models 
with a shorter life expectancy, and therefore a shorter latency period, than humans. 
One mechanism by which LAT could be maintaining latency might be via the transcriptional 
control of ICP0 (Fig. 8), as LAT expression is associated with an increase in unspliced ICP0 
transcripts (Chen et al., 2002a) (Maillet et al., 2006). ICP0 has to be present to ensure 
complete reactivation from latency, with production of infectious virus (Halford and Schaffer, 
2001) (Thompson and Sawtell, 2006). For some of the recently described 16 HSV-1 
microRNAs, an antagonistic effect on viral α-gene products has also been suggested. 
microRNAs are short RNA molecules of about 22 nucleotides in length, capable of hampering 
protein production by binding to complementary mRNA. Most of the HSV-1 microRNAs are 
encoded within the primary LAT transcript, or in genomic regions close to LAT (Cui et al., 
2006) (Umbach et al., 2008) (Umbach et al., 2009) (Jurak et al., 2010), and are differentially 
expressed in productive versus latent infection in mice and humans (Umbach et al., 2008) 
(Umbach et al., 2009) (Jurak et al., 2010). Umbach et al, 2008 showed that microRNA H2-3p 
and microRNA H6 are able to reduce ICP0 and ICP4 expression, respectively, in vitro. 
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Conversely, no significant effect on establishment and maintenance of latent infections was 
observed in mice infected with HSV-1 mutants deficient in the LAT-derived microRNAs and 
microRNA H6 (Kramer et al., 2011). It therefore remains to be resolved, whether viral 
microRNAs and LAT might be more important in humans. With sRNA1 and sRNA2, two 
more small RNAs have been mapped to the LAT region. Both were shown to function in 
inhibiting productive infection and apoptosis in mice (Perng and Jones, 2010). 
During latency HSV-1 DNA is in a heterochromatic state with histone markers typical of a 
repressed chromatin structure (Knipe and Cliffe, 2008). This enhanced assembly of hetero-
chromatin, especially in promoters of lytic genes, was shown to correlate with the presence of 
LAT (Wang et al., 2005b).  
LAT was further shown to inhibit apoptosis, thereby promoting survival of latently infected 
neurons (Perng et al., 2000) (Hamza et al., 2007). The anti-apoptotic effects of LAT are medi-
ated by the inhibition of caspase 8- and caspase 9-induced apoptosis (Henderson et al., 2002) 
as well as inhibition of caspase 3 activation by Granzyme B released from CD8+ T cells 
(Jiang et al., 2011).  
 
2.2.3.3 Immunological control of latency 
Immunosuppression is commonly accepted as a trigger for reactivation and severe HSV 
infection in humans (Montgomerie et al., 1969) (Naraqi et al., 1977), thereby implying a role 
of the immune system in control of HSV-1. In fact, a persisting immune cell infiltration, 
together with anti-viral cytokines and chemokines like IFN-γ and TNF-α, were described in 
latently HSV-1-infected sensory ganglia in mice (Shimeld et al., 1995) (Cantin et al., 1995) 
(Halford et al., 1996) and also in humans (Theil et al., 2003a). Immune infiltrates in latently 
HSV-1-infected human TG have been identified to consist primarily of CD3+ T cells, as well 
as some CD68+ macrophages. The majority of infiltrating immune cells are effector memory 
CD8+ T cells, showing markers of recent activation by antigens (Derfuss et al., 2007) (Verjans 
et al., 2007). Very few CD4+ T cells can be found in the human TG at all, usually spread only 
among the axons (Theil et al., 2003a). In HSV-1-uninfected TG, only scattered CD3+ T cells 
are present. A strong correlation between infiltrating T cells and latent infection of the TG by 
HSV-1, but not varicella-zoster virus (VZV) or human herpesvirus 6 (HHV-6), was demon-
strated (Theil et al., 2003a) (Hüfner et al., 2006) (Hüfner et al., 2007).  
In the mouse model of latent HSV-1 infection, expression of Granzyme B is considered as a 
marker for HSV-1-specificity, along with ongoing activation by chronic stimulation (van Lint 
et al., 2005). In humans, some of the CD8+ T cells present in the TG also express 
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Granzyme B. However, a substantial number of TG infiltrating CD8+ T cells that show mark-
ers of activation do not co-express Granzyme B (Derfuss et al., 2007) (Verjans et al., 2007). 
Therefore, some T cells might represent unspecific bystander T cells, which were attracted by 
the inflammatory milieu and entered the TG only because of their activation status. Entry of 
activated but unspecific T cells into the TG has also been described in mice (van Lint et al., 
2005). 
The T cells present in human TG were shown to have clonally expanded TCR β-chains 
(Derfuss et al., 2007) and TCRγ-loci (Verjans et al., 2007), pointing towards an antigen-
driven proliferation of these T cells. Moreover, cultured T-cell lines derived from HSV-1 
latently infected TG, were reactive against HSV-1 proteins (Verjans et al., 2007). 
The TG infiltrating T cells in humans are mainly found to be clustered around neuronal cell 
bodies (Derfuss et al., 2007). A peculiarity of these T cells is that most of them do not directly 
surround LAT+ neurons. This was also found in mice, where spontaneously reactivated 
neurons expressing viral proteins were surrounded by T cells, but most LAT+ neurons were 
found to be free of associated inflammatory cells (Feldman et al., 2002). 
The presence of activated CD8+ T cells in the neuronal tissue raises the question of whether 
MHC class I is expressed by infected neurons. Neurons themselves could present antigen on 
MHC class I to T cells, as Neumann et al., 1995 showed inducible expression of MHC class I 
on neurons by IFN. On the other hand, neuron supporting satellite cells could also play a role 
in antigen presentation (van Velzen et al., 2009). Furthermore, HSV-1 lytic infection in 
mouse TG was described as inducing MHC class I expression on neurons and satellite cells 
(Pereira et al., 1994). 
The functions of these T cells in HSV-1 latency have mostly been studied in the mouse model 
of infection. TG infiltrating CD8+ T cells were shown to prevent HSV-1 from reactivating in 
mouse TG ex vivo cultures in a dose-dependent, antigen-specific and MHC-restricted manner 
(Liu et al., 2000) (Khanna et al., 2003). It was shown that this is mediated by IFN-γ (Liu et 
al., 2000) and Granzyme B (Knickelbein et al., 2008). The vast majority of TG infiltrating 
CD8+ T cells in latently infected mice with a C57BL/6 genetic background were specific for 
HSV-1. About 50% of the local CD8+ T cells recognise the immuno-dominant epitope 
gB(498-505) (Khanna et al., 2003). The other T cells mostly recognise subdominant epitopes 
belonging to early or late gene products expressed before viral DNA synthesis (Sheridan et 
al., 2009) (St Leger et al., 2011). It still has to be resolved which antigen triggers the CD8+ 
T-cell infiltration in latently HSV-1-infected human TG.  
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As destruction of neurons is seen very rarely in mice (Decman et al., 2005) (Esaki et al., 
2010) and never in humans (Theil et al., 2003a), infiltrating CD8+ T cells apparently do not 
release their full cytotoxic capacity. Secretion of anti-viral cytokines, like IFN-γ or TNF-α, 
appears to be the major mode of action of local CD8+ T cells. IFN-γ was demonstrated to 
suppress viral replication immediately after reactivation (Cantin et al., 1999) as well as at late 
stages (Decman et al., 2005). This was partly mediated by the inhibition of ICP0 expression 
(Decman et al., 2005). The release of cytolytic granules by CD8+ T cells present in latently 
infected TG was, however, also observed. Granzyme B, which normally initiates apoptosis by 
cleavage of caspase 3, was shown to degrade ICP4, a viral α-protein required for efficient 
viral gene expression (Knickelbein et al., 2008) (Fig. 8).  
 
2.2.3.4 Reactivation from latency 
The most common trigger for reactivation of latent HSV-1 is stress. It has been shown that 
psychological stress, either by disruption of the social hierarchy within mouse colonies 
(Padgett et al., 1998), or by restraint (Bonneau, 1996) (Freeman et al., 2007), induced reacti-
vation in mice by reducing the number and functionality of HSV-1-specific CD8+ T cells. In 
humans, immunosuppression caused by stress also led to increased reactivation of HSV 
(Sainz et al., 2001).  
Glucocorticoids not only reduce T-cell numbers in the TG of mice latently infected with 
HSV-1 (Himmelein et al., 2011), but can also regulate gene expression and cause changes in 
the chromatin status (Adcock, 2000). This could lead to activation of viral gene expression. 
An influence of the neuronal excitation status on HSV-1 viral replication has also been 
demonstrated (Zhang et al., 2005). Increased neuronal excitability inhibited viral replication, 
whereas decreased activity of neurons enhanced viral replication. In addition, inhibition of 
histone deacetylases, leading to an increase in transcription, was shown to enhance reactiva-
tion of HSV-1 from latency (Roizman, 2011). These observations suggest that reactivation of 
HSV-1 might be triggered by signals leading to an increase in transcriptional activity of the 
host neuron (Wagner and Bloom, 1997). The molecular mechanism might be that in stressed 
neurons, HCF1 is translocated into the nucleus (Fig. 8). If transcriptional activity is also 
increased within this neuron, VP16 de novo synthesis might occur (Thompson et al., 2009), 
leading to activation of α-promoters. Subsequently, α-proteins like ICP0 or ICP4 can act as 
transactivators of viral gene expression, leading to complete reactivation. At this stage LAT-
derived microRNAs or the infiltrating CD8+ T cells could still repress viral gene expression 
by acting on the transactivating α-transcripts or -proteins. It has been proposed that gene 
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expression during reactivation, at least in explanted mouse TG, is not as ordered as in lytic 
infection (Tal-Singer et al., 1997) (Du et al., 2011). Presumably, as no sensory loss is associ-
ated with repeated reactivation, no neuronal death occurs during the release of virus. Infec-
tious virions are transported in an anterograde manner to the initial site of infection, where 
HSV-1 infects epithelial or mucosal cells and enters the lytic phase. Apparent lesions are less 
frequent than short asymptomatic shedding of the virus (Mark et al., 2008).  
 
 
Fig. 8: Control of HSV-1 latency and reactivation. 
Control of viral latency is believed to be mediated by LAT, infiltrating CD8+ T cells, and host cell 
factors. In stressed neurons HCF1 is translocated into the nucleus and, together with de novo synthe-
sised VP16, can activate α-gene expression. LAT and CD8+ T cells act to repress further viral gene 
expression, but if these control mechanisms are overrun, limited viral replication takes place. Result-
ing viral particles are subsequently transported by anterograde axonal transport to the neuron termini. 
This process probably does not result in lysis of the nerve cell.  
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2.3 Objectives 
The basic question underlying this study is that of the molecular mechanisms that trigger the 
immune response to latent HSV-1 in human TG, an infection with limited viral protein 
production in a site with minimal immune control. This will be addressed from the T cell and 
the neuronal perspective in HSV-1’s natural site of latency, the human TG. The long term aim 
of our work is to understand how HSV-1 latency is maintained and which molecular triggers 
lead to reactivation. 
The first aim of this study is to examine the impact of lifelong chronic HSV-1 infection on the 
TCR repertoire of TG-infiltrating T cells. Previous studies have demonstrated that the TG 
infiltrating CD8+ T cells show markers of recent activation by antigens and are clonally 
expanded. To detect expanded T cell clones, CDR3 spectratyping was applied to TG of 
latently HSV-1-infected individuals. Detection of pervasive T-cell clones with structurally 
homologous or even identical T cell receptors within the TG infiltrating T cells would indi-
cate that these T cells share reactivity to similar antigenic epitopes. 
The second aim is to investigate what mechanisms lead to the puzzling observation made in 
HSV-1 latency that most neurons expressing LAT – the only prominent transcript during 
latency – are free of directly associated T cells, and that most T cells are clustered around 
LAT– neurons. It has been described in mice that some neurons contained viral DNA but do 
not accumulate LAT to detectable levels. A recent study also showed that LAT encodes 
several viral microRNAs, some of which were shown to downregulate expression of the viral 
α-proteins ICP0 and ICP4 in vitro. These α-proteins are required for efficient reactivation 
with de novo production of virions. Therefore we hypothesised that neurons devoid of LAT 
contain viral DNA, and that due to the resulting lack of post-transcriptional control by viral 
microRNAs, HSV-1 α-proteins might be expressed. This potential expression of viral proteins 
would explain why the infiltrating T cells are clustered around some neurons and not others. 
This will be addressed in the current study by combining LAT in situ hybridisation and 
immunohistochemistry for T cells with subsequent single cell analysis of laser microdissected 
neurons for the presence of viral DNA, microRNA, and mRNA. 
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3 Results 
 
This cumulative thesis consists of two accepted publications. In the following results section, 
these publications are included and the contribution of the author to the respective publica-
tions is indicated. All publications of the author, including those which are not included in 
this thesis, are listed separately (list of publications; chapter 7). 
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3.1 Clonal expansions of CD8+ T cells in latently HSV-1-infected human 
trigeminal ganglia 
 
Held K, Eiglmeier I, Himmelein S, Sinicina I, Brandt T, Theil D, Dornmair K, Derfuss T 
(2011) Clonal expansions of CD8+ T cells in latently HSV-1-infected human trigeminal 
ganglia. J Neurovirol., DOI 10.1007/s13365-011-0067-9 
 
 
The author of this doctoral thesis contributed to Held et al. (2011b) by performing CDR3 
spectratyping as well as all immunohistochemical stainings, by carrying out data analysis and 
by writing major parts of the manuscript. 
 
 
Fig. 9: T cells surrounding a neuron.  
Anti-CD3 immunohistochemistry (green) on a 10 µm frozen TG section. The red signal 
originates from lipofuscin. Scale bar, 50µm. 
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Supplementary material 
 
Table S1 All expanded β-chains obtained from the TG used in this study.  
Amino acid sequences of CDR3 are listed. Peak height is given in fluorescent units 
(FU). Subjects 01 to 03 tested positive for HSV-1. Subject 04 testing negative for 
HSV-1 served as negative control. 
 
Subject side Vβ NDN Jβ FU 
AC01 R 1 C A S        T L T G G A G          Y N E Q F F G P G  2.1 198 
AC01 R 1 C A S S V    A V N                  T D T Q Y F G P G  2.3 261 
AC01 L 1 C A S S V    G G P                  N Q P Q H F G D G  1.5 185 
AC01 L 2 C S A R      A P G R H                  E Q Y F G P G  2.7 184 
AC01 L 3 C A S        R A G T G D            N E K L F F G S G  1.4 195 
AC01 R 3 C A S S      F P G T S            S T D T Q Y F G P G  2.3 1801 
AC01 L 5.1 C A S S L    G E G G                S Y E Q Y F G P G  2.7 544 
AC01 L 5.2 C A S S      D R G Q                  S P L H F G N G  1.6 368 
AC01 L 5.2 C A S S      P Q R G                  E K L F F G S G  1.4 310 
AC01 L 5.2 C A S S L    A R G L R A S          T D T Q Y F G P G  2.3 745 
AC01 L 5.2 C A S S L    G D                  S N Q P Q H F G D G  1.5 542 
AC01 L 11 C A S        R T A G              N T G E L F F G E G  2.2 220 
AC01 L 11 C A S S      L S R T G V            N Y G Y T F G S G 1.2 723 
AC01 R 11 C A S S      L S R T G V            N Y G Y T F G S G  1.2 540 
AC01 L 11 C A S S E    Y P                      Y E Q Y F G P G  2.7 568 
AC01 R 13.1 C A S        F P P G G V            S Y N E Q F G X G  2.1 230 
AC01 R 13.1 C A S        R N G G                N Q P Q H F G D G  1.5 213 
AC01 L 13.1 C A S        S L G E G                N E Q F F G P G  2.1 266 
AC01 R 13.2 C A S        S P S Q G G H            Q P Q H F G D G  1.5 239 
AC01 L 13.2 C A S        T W S G R S              Y G Y T F G S G  1.2 250 
AC01 L 14 C A S        R P L G Q G S            Q P Q H F G D G  1.5 210 
AC01 L 14 C A S S      I S G G L D              Y E Q Y F G P G  2.7 485 
AC01 R 14 C A S S      L L Q G                N Y G Y T F G S G  1.2 1046 
AC01 R 17 C A S S      A P G Q S                Y E Q Y F G P G  2.7 1469 
AC01 L 17 C A S S      S T G G D P            S Y E Q Y F G P G  2.7 675 
AC01 L 18 C A S S      P T G D G                  E Q Y F G P G  2.7 450 
AC01 R 20 C A W S      G P V S V G T V        T D T Q Y F G P G  2.3 312 
AC01 R 21 C A S S      L G T G D              T D T Q Y F G P G  2.3 1888 
AC01 L 22 C A S S      D M G P                    G Y T F G S G  1.2 520 
AC01 L 22 C A S S      G P S E I                  E Q F F G P G  2.1 350 
AC01 R 23 C A S S      L R Q                  S Y E Q Y F G P G  2.7 303 
AC01 L 23 C A S S      L R Q                  S Y E Q Y F G P G  2.7 953 
AC01 R 23 C A S S      L W T E D                T E A F F G Q G  1.1 420 
AC01 R 23 C A S S      N P L A G V            T D T Q Y F G P G  2.3 453 
    
 
   
AC02 R 1 C A S S V    G G G                      E Q Y F G P G  2.7 650 
AC02 R 2 C S A        I P I T G P H              E Q Y F G P G  2.7 560 
AC02 R 2 C S A        P Q G A                    E Q F F G X G  2.1 540 
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AC02 R 3 C A S        T Y L D R P              Y E Q Y F G P G  2.7 800 
AC02 R 3 C A S S      T Y P L A E V P T T    Y N E Q F F G P G  2.1 260 
AC02 R 5.1 C A S S      F R A G T S R S T        N E Q F F G P G  2.1 330 
AC02 R 5.1 C A S S L    S P P                  N T E A F F G Q G  1.1 160 
AC02 R 5.2 C A S S L    V Q G D                T G E L F F G E G  2.2 240 
AC02 R 11 C A S S E    S T G S L A                P Q H F G D G  1.5 425 
AC02 R 13.1 C A          S G T G Y                Y G Y T F G S G  1.2 500 
AC02 R 13.1 C A S S Y    D G                  S T D T Q Y F G P G  2.3 630 
AC02 R 14 C A S S      D R T G S                  E Q F F G P G  2.1 260 
AC02 R 14 C A S S      S S G T A                Y G Y T F G S G  1.2 210 
AC02 R 22 C A S S E    M T A                    Y E Q Y F G P G  2.7 880 
AC02 R 22 C A S S S    Y I E P T G            N S P L H F G N G 1.6 2930 
    
 
   
AC03 L 1 C A S S      A Q G T G K P R            E Q Y F G P G  2.7 587 
AC03 L 1 C A S S      P P G Q G T L G A          E A F F G Q G  1.1 250 
AC03 R 3 C A S S      H R G G                  I E Q Y F G P G  2.7 286 
AC03 R 5.1 C A S S      R D                  F Y N E Q F F G X G  2.1 256 
AC03 L 8 C A S        R N D R E                  E Q Y F G P G  2.7 1582 
AC03 L 11 C A S S E    W V S G S                  E Q Y F G P G  2.7 798 
AC03 R 11 C A S S E    W V S G S                  E Q Y F G P G  2.7 1138 
AC03 L 11 C A S S E    Y W G T G              T G E L F F G E G  2.2 191 
AC03 L 13.2 C A S S      N R A A G E Y              T Q Y F G P G  2.3 941 
AC03 R 13.2 C A S S      P P P G                  D T Q Y F G P G  2.3 1673 
AC03 L 13.2 C A S S      R T R Q F A          N T G E L F F G E G  2.2 323 
AC03 R 14 C A S S      I P                  N T G E L F F G E G  2.2 304 
AC03 L 14 C A S S      Q G D S S                N E Q F F G P G  2.1 843 
AC03 R 14 C A S S      S T G F Y                Y E Q Y F G P G  2.7 729 
AC03 R 17 C A S S      P D R A G                  G Y T F G S G 1.2 326 
AC03 L 17 C A S S      P D R A G                  G Y T F G S G 1.2 466 
AC03 R 17 C A S S      P G H L                  Y E Q Y F G P G  2.7 744 
AC03 L 18 C A S S P    W E R T G              S Y E Q Y F G P G  2.7 558 
AC03 R 20 C A          S T L Q P              Y N E Q F F G P G  2.1 207 
AC03 R 20 C A W        N P G I G                Q P Q H F G D G  1.5 220 
AC03 L 20 C A W S      P G W T S G                T Q Y F G P G  2.3 1359 
AC03 R 20 C A W S      P N R A D                Y G Y T F G S G  1.2 371 
AC03 L 20 C A W S V    Q                      N Y G Y T F G S G  1.2 594 
AC03 L 21 C A S S L    G Q G A S            S Y N E Q F F G P G  2.1 271 
AC03 L 22 C A S S E    S G K R I S                G Y T F G S G 1.2 270 
    
 
   
AC04 L 1 C A S        V R A T              S T D T Q Y F G P G 2.3 630 
AC04 L 5.1 C A S S      P G Q G G              N Q P Q H F G D G  1.5 320 
AC04 L 8 C A S S      I K T G R G              G K L F F G S G  1.4 240 
AC04 L 8 C A S S      P P S A G S L G V          E A F F G Q G 1.1 180 
AC04 L 11 C A S S      G Q G W G                T E A F F G Q G  1.1 560 
AC04 L 13.1 C A S S      V S S G M N            T D T Q Y F G P G  2.3 460 
AC04 L 14 C A S S      F G T G E                  G Y T F G S G  1.2 600 
AC04 L 14 C A S S      G G T G G              N Q P Q H F G D G  1.5 480 
AC04 L 20 C A W        T W S S G L            Y N E Q F F G P G  2.1 180 
AC04 L 23 C A S S L    R R G Q                    P Q H F G X G  1.5 280 
Results 
37 
 
Fig. S1 Micrograph showing a representative DNA sequencer gel.  
PCR products separated on this gel stem from subject 04, the negative control, in 
which mono- (orange arrow) or oligoclonal expansions (pink arrow) appear as peaks 
of certain CDR3 length over a Gaussian background of polyclonal T cells (white 
arrow). PCR products from Vβ-Jβ amplification were applied to lanes 1 to 30, 
whereas in lanes 31 to 36 Vβ-Cβ PCR products were separated. 
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3.2 Expression of herpes simplex virus 1-encoded microRNAs in human 
trigeminal ganglia and their relation to local T-cell infiltrates 
 
Held K, Junker A, Dornmair K, Meinl E, Sinicina I, Brandt T, Theil D, Derfuss T (2011) 
Expression of herpes simplex virus 1-encoded microRNAs in human trigeminal ganglia and 
their relation to local T-cell infiltrates. J Virol., 85, 9680-9685 
 
 
The author of this doctoral thesis contributed to Held et al. (2011a) by conducting most 
experiments except microRNA quantitative polymerase chain reactions (PCR) and the immu-
nohistochemical staining for Fig. 1A. Furthermore, the author analysed all data and wrote 
parts of the manuscript. 
 
 
 
Fig. 10: Latently HSV-1-infected neuron and TG infiltrating T cells.  
LAT in situ hybridisation (dark nuclear staining) and anti-CD3 immunohistochemistry (brown 
surface staining) on a 10 µm frozen TG section, counterstained with methyl green. Scale bar, 
50µm. 
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4 Discussion 
To study the TCR repertoire of the T-cell infiltrates present in human TG, CDR3 spectratyp-
ing was applied. Several clonal expansions were found within all assessed TG. One finding of 
particular note is that identical TCR chains were found in the left and right ganglia from the 
same individual. This provides direct evidence for antigen-driven T-cell responses. These 
expansions were not shared between individuals, which can be expected due to the different 
HLA haplotypes of the subjects.  
Analysis of the distribution of the immune cell infiltrates amongst neuronal cell bodies 
revealed that most LAT+ neurons are not closely associated with T cells. Quite a few neurons 
negative for LAT by in situ hybridisation were, however, surrounded by T cells. This raises 
the question of whether these LAT– neurons surrounded by T cells harbour latent HSV-1 
genomes. In mouse TG it has been established that numerous LAT– neurons containing 
HSV-1 DNA are present (Chen et al., 2002a). Our present examination of single laser micro-
dissected neurons from human TG showed that only LAT+ neurons actually harbour HSV-1, 
indicating a more fundamental role of LAT in human HSV-1 latency. 
Both studies add further knowledge of the role of the TG infiltrating CD8+ T cells and viral 
transcripts like LAT and microRNAs in the maintenance of HSV-1 latency in its natural host, 
the human. Altogether, the results indicate that latency is tightly controlled by viral and 
cellular control mechanisms. The host immune system, in this case the virus-specific CD8+ 
T cells, only come into action if these mechanisms are overrun. 
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4.1 The infiltrating T cells are clonally expanded 
To investigate how latent viral infections may shape the TCR repertoire of the TG infiltrating 
T cells, the sequences of hypervariable TCR CDR3-regions were analysed (chapter 3.1). 
Given that HSV-1 establishes lifelong latency in the sensory neurons and repeatedly reacti-
vates from there, it can be assumed that the lifelong exposure to viral antigen has shaped the 
TCR usage of the local T cells. Further, as herpesviruses are estimated to be 400 million years 
old, and HSV-1 and humans have therefore co-existed for a very long time, some TCRs 
universally reactive to this virus might have evolved. Such strong biases in the blood TCR 
repertoire have been described for herpes simplex virus type 2 (HSV-2) (Dong et al., 2010) as 
well as the human herpesviruses Epstein-Barr virus (EBV) and cytomegalovirus (HCMV) 
(Venturi et al., 2008). In the present study, using CDR3 spectratyping, clonally expanded 
TCR β-chains were detected in all analysed TG. Even though the analysed subjects shared 
some HLA alleles, however, no public T-cell clones occurring in more than one subject were 
identified. Studies analysing the TCR repertoire present in the brain of multiple sclerosis 
patients showed that distinct T-cell clones appeared in different anatomical sites (Skulina et 
al., 2004) (Junker et al., 2007). Here, the right and the left TG from two subjects were 
screened independently for clonal expansions. Some homologous clones were found to occur 
in both TG. Homologous clones share Vβ-segments and further exhibit amino acids with 
similar properties in their CDR3. Amino acids in positions three to five after the conserved 
cysteine have been shown to be especially important for antigen binding (Rudolph et al., 
2006). The presence of homologous clones indicates that these T cells proliferated to similar 
antigenic epitopes. Remarkably, each of the subjects from which both TG were analysed, 
revealed two identical clones in both TG. These clones present in the right and the left TG 
even shared identical nucleotide sequences, suggesting that they originate from the same 
T-cell clone, which was probably primed in the periphery and subsequently infiltrated both 
latently infected TG. 
Staining for expanded Vβ-chains in the present study revealed that not all of the CD8+ T cells 
clustered around a neuronal cell body belong to the same T-cell clone, indicating different 
reactivities in these T-cell clusters. This also hints towards an infiltration of the TG by acti-
vated but unspecific bystander T cells. Verjans, et al 2007 have also proposed this on the 
basis that most T cells present in TG express markers of activation but only a few co-express 
Granzyme B, which is considered as a marker for specificity in mice (van Lint et al., 2005). 
Van Lint et al, 2005 further found that initial infiltration of activated T cells into latently 
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infected mouse TG was independent of T-cell specificity. Infiltration of activated but unspe-
cific T cells to sites with a chronic inflammatory milieu has also been described in rheumatoid 
arthritis patients (Scotet et al., 1999). CD8+ T cells reactive against viral proteins derived from 
EBV and HCMV were found to be enriched within inflamed joints. In the present study 
homologous and even identical clones were detected in the right and the left TG, and thus it 
seems likely that these clones were attracted by specific antigens expressed in both TG.  
On the other hand, in mice latently infected with HSV-1, it was shown that almost all local 
T cells are reactive against HSV-1-derived antigenic epitopes (St Leger et al., 2011), with 
gB(498-505) being the immuno-dominant epitope in C57BL/6 mice. In mice the overall immu-
nological control of HSV-1 therefore appears to be more thorough than in humans. There are 
three obvious reasons for this: first, HSV-1 ICP47 restricts MHC class I antigen presentation 
less efficiently in mice than in humans (Orr et al., 2007). Second, rare expression of numerous 
viral proteins was found to occur in mouse TG (Feldman et al., 2002), but not in humans 
(Theil et al., 2003a). Third, laboratory mice are only infected by HSV-1 and do not show an 
age-related accumulation of CD8+ T cells reactive to other viruses like HCMV, as seen in 
elderly humans (Karrer et al., 2009). 
Given that the epitopes responsible for triggering the immune infiltration into HSV-1-infected 
TG in humans have not yet been identified, the candidate antigens of the clonally expanded 
TG infiltrating T cells can only be speculated. HSV-1 can be considered as the initial trigger, 
since a positive correlation between these TG infiltrating immune cells and the presence of 
latent HSV-1, but not VZV or HHV-6, could be established (Theil et al., 2003a) (Hüfner et 
al., 2006) (Hüfner et al., 2007) (Arbusow et al., 2010). Also, the two studies presented here 
show significantly more T cells in latently HSV-1-infected TG than in TG negative for 
HSV-1. Both the number of CD3+ T cells (chapter 3.1), as well as the number of neurons 
surrounded by CD3+ T cells (chapter 3.2), are elevated in latently HSV-1-infected human TG. 
This was not observed when VZV-infected TG were compared to VZV-uninfected TG. Most 
convincingly, Verjans et al, 2007 showed that some T-cell lines isolated from human TG 
were reactive to B cells presenting HSV-1, but not VZV, antigens. 
In humans, it is more feasible to study the reactivity of blood-derived T cells than TG derived 
ones. It was shown that human CD4+ and CD8+ blood T cells differ in antigen-specificity 
(Mikloska and Cunningham, 1998). CD4+ T cells, which usually encounter free virus, mostly 
recognised structural viral proteins produced late in the lytic cycle. On the other hand, CD8+ 
T cells mainly reacted to viral proteins produced early in the lytic cycle, therefore being able 
to kill virus infected cells before viral replication starts. In searching for candidate T-cell 
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antigens in human latency, however, it has to be considered that HSV-1 remains almost tran-
scriptionally silent during this period. So far, no viral antigens were found to be expressed in 
human TG during latency (Theil et al., 2003a), and whether LAT, the only readily detectable 
transcript during latency, encodes for a protein is still a matter of debate (Henderson et al., 
2009). The α-proteins ICP0 and ICP4 might be candidate antigens, though, as low level 
expression of these genes was detected in some latently HSV-1-infected human TG by 
Derfuss et al, 2007, as well as in the present study. 
Future work might identify the antigenic epitopes for CD8+ T cells in latently HSV-1-infected 
human TG. This could be done with human TG, obtained very shortly after death, and there-
fore containing viable T cells. Stable T-cells lines could be generated from these TG and used 
for an exact epitope mapping. Alternatively, tissue-infiltrating T cells in close contact with 
neurons could be excised from TG sections by laser microdissection with subsequent recon-
stitution of the TCR as described in (Seitz et al., 2006). The reconstituted TCR could then be 
used to screen for the antigen (Siewert et al., 2011). Identification of the TCR repertoire 
present in the TG could also clarify whether the reactivity of tissue-residing T cells differs 
from blood T cells. Further studies might also address changes in the human TCR repertoire 
occurring with ageing, and therefore prolonged exposure to latent HSV-1. It further remains 
to be resolved whether a single immuno-dominant epitope can be identified in humans or if – 
as is more likely – the epitopes vary, especially among subjects with different HLA-alleles.  
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4.2 Colocalisation of infiltrating T cells and latent HSV-1 in human TG 
Since it was shown that several herpesviruses can establish latency in human TG (Liedtke et 
al., 1993) (Pevenstein et al., 1999) (Theil et al., 2003b) (Hüfner et al., 2007), it is important to 
determine which virus triggers the immune infiltration into the TG. So far, a strong correla-
tion between HSV-1 latency and infiltrating T cells has been demonstrated for whole ganglia, 
and no co-occurrence of immune cells with VZV or HHV-6 was found (Theil et al., 2003a) 
(Hüfner et al., 2006) (Hüfner et al., 2007). It was further shown that T-cell infiltrates are 
localised in the same division of human TG as HSV-1 latently infected neurons (Hüfner et al., 
2009). In humans, usually infected via the mouth, the mandibular and maxillary division were 
found to mostly harbour latent HSV-1 as well as T cells. In accordance with this, in mice 
infected with HSV-1 via the eye, a more prominent T-cell infiltration to the ophthalmic divi-
sion was observed (Khanna et al., 2003). Reactivity of the CD8+ T cells from human TG was 
demonstrated to HSV-1 but not VZV (Verjans et al., 2007), which may be the most convinc-
ing argument.  
Surprisingly, it was noted that most T cells did not surround neurons that showed a positive 
staining signal in LAT in situ hybridisation (Theil et al., 2003a) (Derfuss et al., 2007). In the 
present study (chapter 3.2), a detailed quantification of this peculiarity was carried out by 
counting T-cell-neuron interaction patterns on TG sections co-stained for HSV-1 LAT and 
CD3+ T cells. It was shown that 4.2% of all TG neurons were closely surrounded by T cells, 
with 95.5% of them negative for LAT by in situ hybridisation. 1.3% of all TG neurons were 
positive for LAT, with only 13.3% of LAT+ neurons being surrounded by T cells. However, 
overall numbers of LAT+ neurons still correlated with the overall number of neurons 
surrounded by T cells in the TG. Staining of consecutive sections confirmed the consistency 
of these results. The numbers of LAT+ neurons in human TG are in line with the report of 
Wang et al, 2005a, who detected LAT expression in 0.2 to 1.5 % of human TG neurons.  
There are several potential explanations for the three different T-cell-neuron interaction 
patterns observed. (I) In mice it has been established that several neurons harbour HSV-1 
DNA, but do not accumulate LAT to detectable levels (Chen et al., 2002b). This was 
confirmed in a study using human TG (Wang et al., 2005a). We therefore hypothesised that 
the neurons surrounded by T cells but devoid of LAT, do actually contain HSV-1 DNA. (II) 
To attract CD8+ T cells, viral proteins need to be expressed and presented on MHC class I. As 
mentioned above, viral LAT-derived microRNAs were shown to facilitate downregulation of 
ICP0 and ICP4 translation in vitro (Umbach et al., 2008). This led to the hypothesis that 
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differential expression of viral microRNAs might cause the different T-cell-neuron interaction 
patterns. In neurons with no detectable LAT expression, microRNA levels would be low, and 
therefore viral proteins might be minimally expressed, leading to the attraction of T cells. (III) 
In LAT expressing neurons not surrounded by T cells, microRNA levels seem to be sufficient 
to block viral protein synthesis. 
To study why the infiltrating T cells are clustered around some neurons and not around others, 
TG sections were stained for LAT and CD3, and subsequently single neurons were excised 
using laser microdissection. Microdissected neurons were then analysed by PCR for the pres-
ence of viral DNA, HSV-1 microRNAs, and mRNA for the α-gene ICP0. Signs of the virus 
were only detected in neurons positive for LAT by in situ hybridisation, and neither the 
amount of viral DNA nor the amount of viral microRNAs correlated with the T-cell infil-
trates. Furthermore, the T cells were also not attracted by HSV-2 or VZV, as neurons 
surrounded by T cells tested negative for these viruses by quantitative PCR.  
The present study is the first to show that, in humans, all latently infected neurons do express 
LAT. This indicates that LAT plays a more important role in HSV-1 latency in humans than 
in small animal models of infection. The contradictive results to an earlier study in human TG 
(Wang et al., 2005a), which analysed the presence of HSV-1 and VZV DNA in human TG 
and found HSV-1 DNA also in LAT– neurons and non-neuronal cells, might be explained by 
differences in the experimental procedures. Firstly, in the present study frozen TG were used, 
instead of paraffin fixed TG. Further, a different in situ hybridisation protocol and probe, as 
well as different quantitative PCR protocols, were used. The present use of a PCR kit 
approved for diagnostics should rule out unspecific positive results. Also, Wang et al, 2005a 
used a laser capture microdissection PixCell II microscope (Arcturus Engineering, Inc., USA) 
to excise single neurons, where a membrane is melted onto the neurons in question. This 
might lead to contaminations by nearby HSV-1 positive neurons. Here, laser catapulting 
microdissection (Zeiss, Germany) was used, thereby avoiding such contaminations. This 
might explain why Wang et al, 2005a found HSV-1 DNA also in non-neuronal cells. 
However, average HSV-1 copy numbers, as well as the observation that the majority of 
neurons do not harbour more than 20 HSV-1 DNA copies, are in accordance with the results 
of the work presented in this thesis. To ensure sensitivity of our quantitative PCR protocol, 
titration experiments were carried out, resulting in a recovery rate of 50% for one HSV-1 
copy, diluted in DNA from HSV-1 negative TG.  
Our observation that LAT is expressed in all latently HSV-1-infected TG neurons was also 
confirmed by F. Catez and P. Lomonte (personal communication). A double-fluorescent in 
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situ hybridisation for HSV-1 DNA and LAT on human TG sections did not show DNA+ 
neurons that were negative for LAT. 
One major question still remains. What actually attracts T cells to neurons devoid of LAT and 
viral DNA? It can be speculated that these neurons used to be latently infected by HSV-1 but 
the virus reactivated and was subsequently cleared by the immune system. As it is not known 
whether neurons die upon viral reactivation, or whether some viral genomes do remain latent 
in neurons after a reactivation event, this cannot be excluded. Moreover, it has been shown for 
HSV-2 that T cells remain in the skin long after infectious virus has been cleared (Gebhardt et 
al., 2009). The T cells surrounding LAT– neurons could also be virus-unspecific bystander 
T cells that have been attracted by the inflammatory milieu. It also cannot be excluded that 
these neurons harbour very little viral DNA, which was below the detection limit of the PCR 
protocol applied here. CD8+ T cells are able to react to such small numbers of antigen:MHC 
class I complexes as 1 to 3 on one cell (Sykulev et al., 1996) (Purbhoo et al., 2004). A study 
analysing the differences in the transcriptome of neurons surrounded by T cells versus 
neurons free of T cells might give further insight into this paradox. This might also resolve 
the question of whether MHC class I expression is upregulated in these neurons. 
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4.3 Model of latent HSV-1 infection in humans 
The overall conclusion of this study is that the T cell population observed throughout human 
TG is triggered by latent HSV-1 infection. It was demonstrated that these T cells possess 
clonally expanded TCR β-chains. These clones were private to the assessed individuals as no 
T-cell clone occurred in different individuals. However, homologous and identical clones 
present in both TG of one individual were found. This indicates presence of the same T-cell 
antigen in both TG. The fact that T-cell clones identical even in their nucleotide sequence 
were found in both TG implies that these clones originate from the same T cell. This T cell 
was most probably primed in the periphery during primary HSV-1 infection. Upon arrival of 
the virus in the TG, some of these activated T-cell clones, along with other activated T cells, 
infiltrated into the tissue. Repeated recognition of their respective antigen resulted in prolif-
eration and secretion of cytokines and chemokines, creating an inflammatory milieu that 
attracted more T cells, some of which could be unspecific (Fig. 11). 
 
 
Fig. 11: Schematic model of the events after HSV-1 primary infection with special focus on T cells. 
Upon primary infection, HSV-1 proliferates in the mucosal and epithelial cells. HSV-1 specific CD8+ 
T cells are activated and proliferate. After HSV-1 is transported via retrograde axonal transport to the 
TG, also activated virus-specific CD8+ T cells enter the TG. Recognition of their respective antigens 
leads to secretion of cytokines and chemokines, resulting in the attraction of other activated T cells, 
some probably also unspecific. 
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An important finding of the current study is that LAT, as the only prominent transcript during 
latency, is expressed in all neurons containing HSV-1 DNA. LAT therefore seems to play a 
more crucial role in the maintenance of latency in humans than in small animal models of 
infection. An intra-species variation in the effect of LAT on spontaneous reactivation has 
already been shown (Hill et al., 1990) (Perng et al., 1994) (Margolis et al., 2007). This corre-
lates with the ability of HSV-1 to reactivate spontaneously, which is a hallmark of human 
infection. Spontaneous reactivation is also more common in rabbits than in mice (Wagner and 
Bloom, 1997). Additionally, in the present study the LAT-derived microRNAs, as well as 
microRNA H6, were found to be present in all latently infected neurons. It was shown that 
microRNA H2-3p and microRNA H6 were downregulating ICP0 or ICP4 translation, respec-
tively, in vitro (Umbach et al., 2008), thus ensuring that an interruption in viral gene repres-
sion does not lead to spontaneous reactivation. 
Overall, the following model for the maintenance of HSV-1 latency can be envisioned: in 
most latently infected neurons, restriction of viral transcription by packaging of the viral 
genome into heterochromatin is sufficient to maintain latency. However, if transient instabili-
ties in the heterochromatin occur, viral microRNAs encoded by the LAT locus are present to 
hamper transcription of viral α-proteins. The induction of full blown viral replication is 
thereby prevented (Fig. 12A). Triggers like stress might, however, induce changes in the 
chromatin structure of viral genomes that overrun these control mechanisms. Then the tissue-
infiltrating CD8+ T cells might step in and, via the secretion of IFN-γ and Granzyme B, hinder 
full blown reactivation of the virus (Fig. 12B). 
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Fig. 12: Model of the maintenance of viral latency in neurons. 
A: In most neurons latency is maintained by the combined actions of chromatin control and LAT. 
B: Stress might lead to increased transcriptional activity within the neuron as well as translocation of 
HCF1 into the nucleus. This might overrun the capacity of microRNAs, and the CD8+ T cells serve as 
a second line of defence, stopping viral replication in a non-cytolytic manner.  
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6 Abbreviations 
APC  antigen-presenting cell 
CDR  complementarity determining region 
ds  double-stranded 
EBV  Epstein-Barr virus 
ER  endoplasmic reticulum 
g  glycoproteins 
HCF1  host cell factor 1 
HCMV human cytomegalovirus 
HLA  human leukocyte antigen 
HSV-1  herpes simplex virus type 1 
HSV-2  herpes simplex virus type 2 
ICP  infected cell protein 
IFN  interferon 
kb  kilo base pairs = 1,000 base pairs 
LAT  latency associated transcript 
MHC  major histocompatibility complex 
n  number 
Oct1  octamer binding protein 1 
ORF  open reading frame 
ori  origin of replication 
SEM  standard error of the mean 
TAP  transporter associated with antigen processing 
TCR  T-cell receptor 
TG  trigeminal ganglia 
TNF  tumour necrosis factor 
vhs  virus host shutoff 
VZV  varicella-zoster virus 
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8 Zusammenfassung 
Das Herpes-Simplex-Virus Typ 1 (HSV-1) ist ein doppel-strängiges DNA Virus, welches 
Menschen infiziert und nach einer primären lytischen Infektion eine lebenslange Latenz in 
den sensorischen Neuronen der Trigeminus-Ganglien (TG) etabliert. Die HSV-1 Latenz wird 
von einer chronischen Immunzellinfiltration begleitet, welche hauptsächlich aus CD8+ 
T-Zellen besteht. Es wird angenommen, dass diese T-Zellen die virale Latenz kontrollieren. 
Jedoch scheinen auch zelluläre und virale Faktoren, wie zum Beispiel virale microRNAs eine 
zentrale Rolle in der Etablierung und dem Erhalt der Latenz zu spielen.  
In der vorliegenden Arbeit wurde untersucht, ob die in die TG eingewanderten T-Zellen 
klonal expandiert sind. Dies würde bedeuten, dass sie durch ein Antigen aktiviert wurden. 
Unter der Anwendung von CDR3-Spektratypisierung, einer Methode welche die Längenver-
teilung der hypervariablen Region 3 des T-Zell-Rezeptors analysiert, sowie Immunhistoche-
mie, konnten klonale Expansionen bei den T-Zellen in den TG nachgewiesen werden, wovon 
einige unspezifische „bystander“ T-Zellen zu sein schienen. Bemerkenswerterweise wurden 
einige identische T-Zell-Klone im rechten und linken TG eines Individuums gefunden, was 
auf die Anwesenheit gleicher Antigene in beiden TG schließen lässt. Außerdem kann daher 
angenommen werden, dass eine Immunzellinfiltration in die TG durch Antigene ausgelöst 
wird.  
Die Morphologie der TG wurde mittels Immunhistochemie und In-situ-Hybridisierung unter-
sucht. Die Analyse der Verteilung der T-Zellen im TG führte zu unerwarteten Ergebnissen. 
Die meisten der von T-Zellen umgebenen Neurone enthielten kein Latenz-assoziiertes 
Transkript (LAT), welches das einzige bekannte häufig transkribierte Genprodukt der viralen 
Latenz darstellt. Eine Kombination aus LAT In-situ-Hybridisierung, T-Zell Immunhistoche-
mie und PCR-Analyse von einzelnen, durch Lasermikrodissektion gewonnenen Neurone 
sollte Aufschluss darüber geben, ob diese Neurone tatsächlich Viren enthalten. Diese Analyse 
zeigte, dass nur LAT+ Neurone HSV-1 DNA oder virale microRNAs enthielten. So konnte 
auch mRNA für ein virales Genprodukt nur in LAT+ Neuronen nachgewiesen werden. In 
keinem der hier analysierten LAT– Neurone konnten virale microRNAs sowie HSV-1 DNA 
nachgewiesen werden. DNA für HSV-2 oder Varizella-Zoster-Virus (VZV) war in keinem 
der untersuchten einzelnen Neurone vorhanden. Zusammengefasst lässt sich für den 
Menschen sagen, dass in der Mehrheit der infizierten Neurone die HSV-1 Latenz nicht direkt 
durch T-Zellen kontrolliert wird, sondern eher durch zelluläre oder virale Faktoren wie zum 
Beispiel die viralen microRNAs. Unsere Daten lassen darauf schließen, dass CD8+ T-Zellen 
nur dann in Aktion zu treten scheinen, wenn diese Faktoren nicht mehr ausreichen. 
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